Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "golden Years" type 1 diabetes mellitus cohort

Metabolism: Clinical and Experimental

Volumn 60, Issue 2, 2011, Pages 173-179

  Prior, Sarah Lyn ^a   Tang, Ting Seng ^a   Gill, Geoff V ^b   Bain, Steve C ^a   Stephens, Jeffrey W ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALBUMIN; ANTIOXIDANT; CREATININE; INSULIN;

AGED; ALBUMINURIA; ARTICLE; BODY MASS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; SEX DIFFERENCE; URINARY EXCRETION;

ADIPONECTIN; AGED; ALBUMINURIA; ANTIOXIDANTS; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SEX FACTORS;

EID: 78751647636     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.12.008     Document Type: Article

References (45)

1. Jorsal A., Tarnow L., Frystyk J., Lajer M., Flyvbjerg A., and Parving H.H. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy Kidney Int 2008
2. Schalkwijk C.G., Chaturvedi N., Schram M.T., Fuller J.H., and Stehouwer C.D. Adiponectin is inversely associated with renal function in type 1 diabetic patients J Clin Endocrinol Metab 91 2006 129 135
3. Saraheimo M., Forsblom C., Fagerudd J., Teppo A.M., Pettersson-Fernholm K., and Frystyk J. Serum adiponectin is increased in type 1 diabetic patients with nephropathy Diabetes Care 28 2005 1410 1414
4. Frystyk J., Tarnow L., Hansen T.K., Parving H.H., and Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications Diabetologia 48 2005 1911 1918 (Pubitemid 41317848)
5. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., and Okamoto Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
6. Shimabukuro M., Higa N., Asahi T., Oshiro Y., Takasu N., and Tagawa T. Hypoadiponectinemia is closely linked to endothelial dysfunction in man J Clin Endocrinol Metab 88 2003 3236 3240
7. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., and Miyagawa J. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
8. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., and Tataranni P.A. Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 2002 57 58
9. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., and Ouchi N. Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
10. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., and Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension Am J Hypertens 16 2003 72 75
11. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., and Matsui J. Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem 277 2002 25863 25866
12. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., and Hara K. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
13. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., and Hioki K. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem 278 2003 2461 2468
14. Hattori S., Hattori Y., and Kasai K. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats Metabolism 54 2005 482 487
15. Tao L., Gao E., Jiao X., Yuan Y., Li S., and Christopher T.A. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress Circulation 115 2007 1408 1416
16. Li R., Wang W.Q., Zhang H., Yang X., Fan Q., and Christopher T.A. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity Am J Physiol Endocrinol Metab 293 2007 E1703 E1708
17. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., and Nakajima Y. Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761
18. Nakanishi S., Yamane K., Kamei N., Nojima H., Okubo M., and Kohno N. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane Metabolism 54 2005 194 199
19. Sharma K., Ramachandrarao S., Qiu G., Usui H.K., Zhu Y., and Dunn S.R. Adiponectin regulates albuminuria and podocyte function in mice J Clin Invest 118 2008 1645 1656
20. Rudofsky G. Jr., Schlimme M., Schlotterer A., von Eynatten M., Reismann P., and Tafel J. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications Diabetes Obes Metab 7 2005 455 459
21. Schaffler A., Herfarth H., Paul G., Ehling A., Muller-Ladner U., and Scholmerich J. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2 Exp Clin Endocrinol Diabetes 112 2004 383 389 (Pubitemid 38915716)
22. Ma J., Mollsten A., Falhammar H., Brismar K., Dahlquist G., and Efendic S. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy J Diabetes Complications 21 2007 28 33
23. Chudek J., Adamczak M., Karkoszka H., Budzinski G., Ignacy W., and Funahashi T. Plasma adiponectin concentration before and after successful kidney transplantation Transplant Proc 35 2003 2186 2189 (Pubitemid 37194359)
24. Adamczak M., Szotowska M., Chudek J., Karkoszka H., Cierpka L., and Wiecek A. Plasma adiponectin concentration in patients after successful kidney transplantation-a single-center, observational study Clin Nephrol 67 2007 381 390
25. Cochran H.A. Jr., Marble A., and Galloway J.A. Factors in the survival of patients with insulin-requiring diabetes for 50 years Diabetes Care 2 1979 363 368
26. Orchard T.J., Dorman J.S., Maser R.E., Becker D.J., Ellis D., and LaPorte R.E. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I Diabetes Care 13 1990 741 747 (Pubitemid 20207423)
27. Bain S.C., Gill G.V., Dyer P.H., Jones A.F., Murphy M., and Jones K.E. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort) Diabet Med 20 2003 808 811
28. Amin R., Bahu T.K., Widmer B., Dalton R.N., and Dunger D.B. Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study Arch Dis Child 90 2005 1039 1044
29. Amin R., Frystyk J., Ong K., Dalton R.N., Flyvbjerg A., and Dunger D.B. The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes Diabetologia 51 2008 1707 1713
30. Magliano D.J., Polkinghorne K.R., Barr E.L., Su Q., Chadban S.J., and Zimmet P.Z. HPLC-detected albuminuria predicts mortality J Am Soc Nephrol 18 2007 3171 3176
31. Sampson M.J., Gopaul N., Davies I.R., Hughes D.A., and Carrier M.J. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes Diabetes Care 25 2002 537 541
32. Stephens J.W., Gable D.R., Hurel S.J., Miller G.J., Cooper J.A., and Humphries S.E. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males Clin Chem 52 2006 446 452
33. Rothman K.J. No adjustments are needed for multiple comparisons Epidemiology 1 1990 43 46
34. Galler A., Gelbrich G., Kratzsch J., Noack N., Kapellen T., and Kiess W. Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study Eur J Endocrinol 157 2007 481 489
35. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., and Matsubara K. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population Clin Sci (Lond) 103 2002 137 142
36. Leth H., Andersen K.K., Frystyk J., Tarnow L., Rossing P., and Parving H.H. Elevated levels of high-molecular-weight adiponectin in type 1 diabetes J Clin Endocrinol Metab 93 2008 3186 3191
37. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., and Kita S. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin J Biol Chem 278 2003 40352 40363
38. Kovac I.P., Havlik R.J., Foley D., Peila R., Hernandez D., and Wavrant-De Vrieze F. Linkage and association analyses of type 2 diabetes/impaired glucose metabolism and adiponectin serum levels in Japanese Americans from Hawaii Diabetes 56 2007 537 540
39. Fernandez-Real J.M., Botas-Cervero P., Lopez-Bermano A., Casamitjana R., Funahashi T., and Delgado E. Adiponectin is independently associated with glycosylated haemoglobin Eur J Endocrinol 150 2004 201 205
40. Saraheimo M., Forsblom C., Thorn L., Waden J., Rosengard-Barlund M., and Heikkila O. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes Diabetes Care 31 2008 1165 1169
41. Mehrotra S., Ling K.L., Bekele Y., Gerbino E., and Earle K.A. Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with type 2 diabetes mellitus Diabet Med 18 2001 109 115
42. Stephens J.W., Khanolkar M.P., and Bain S.C. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease Atherosclerosis 2008
43. Dhamrait S.S., Stephens J.W., Cooper J.A., Acharya J., Mani A.R., and Moore K. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2 Eur Heart J 25 2004 468 475
44. Salpea K.D., Talmud P.J., Cooper J.A., Maubaret C.G., Stephens J.W., and Abelak K. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation Atherosclerosis 2009
45. Stephens J.W., Dhamrait S.S., Mani A.R., Acharya J., Moore K., and Hurel S.J. Interaction between the uncoupling protein 2 -866G>A gene variant and cigarette smoking to increase oxidative stress in subjects with diabetes Nutr Metab Cardiovasc Dis 18 2008 7 14